Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants

Clinical trial NCT07550816 · RECRUITING

Trial details

NCT number: NCT07550816
Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight,Obesity

Start date: 2026-05-27
Primary completion: 2026-12-05
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.